Guideline 'dyspepsia';Richtlijn 'maagklachten'

Nederlands Tijdschrift voor Geneeskunde

Volumn 149, Issue 25, 2005, Pages 1386-1392

  De Wit, N J ^a   Van Barneveld, T A ^b   Festen, H P M ^c   Loffeld, R J L F ^d   Van Pinxteren, B ^e   Numans, M E ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Dutch Institute for Healthcare Improvement CBO   (Netherlands)

^c JEROEN BOSCH HOSPITAL   (Netherlands)

^d ZAANS MEDICAL CENTER   (Netherlands)

^e DUTCH COLLEGE OF GENERAL PRACTITIONERS   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

ANEMIA; BLEEDING; DIAGNOSTIC TEST; DISEASE SEVERITY; DRUG EFFICACY; DUODENUM ULCER; DYSPEPSIA; DYSPHAGIA; ENDOSCOPY; ESOPHAGITIS; GASTROESOPHAGEAL REFLUX; HELICOBACTER PYLORI; HIGH RISK PATIENT; HUMAN; LONG TERM CARE; PEPTIC ULCER; PRACTICE GUIDELINE; PROGNOSIS; RECURRENT DISEASE; REVIEW; SYMPTOMATOLOGY; TREATMENT INDICATION; WEIGHT REDUCTION;

ANTACIDS; DIAGNOSIS, DIFFERENTIAL; DYSPEPSIA; ENDOSCOPY; GASTROENTEROLOGY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS;

EID: 20844463276     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Jones R, Lydeard S. Prevalence of symptoms of dyspepsia in the community. BMJ 1989;298:30-2.
2. Bommel MJ van, Numans ME, Wit NJ de, Stalman WA. Consultations and referrals for dyspepsia in general practice - a one year database survey. Postgrad Med J 2001;77:514-8.
3. Velde J van de, Bakker DH de, Claessens AAMC, Schellevis FG. Een nationale Studie naar ziekten en verrichtingen in de huisartspraktijk. Basisrapport: morbiditeit in de huisartspraktijk. Utrecht: NIVEL; 1991.
4. Quartero AO, Post MW, Numans ME, Melker RA de, Wit NJ de. What makes the dyspeptic patient feel ill? A cross sectional survey of functional health status, Helicobacter pylori infection, and psychological distress in dyspeptic patients in general practice. Gut 1999;45:15-9.
5. GIPsignaal - Gebruik van maagmiddelen, 1996-2001. Amstelveen: College voor zorgverzekeringen; 2002.
6. Quartero AO, Smeets H, Wit NJ de. Trends and determinants of pharmacotherapy for dyspepsia: analysis of 3-year prescription data in the Netherlands. Scand J Gastroenterol 2003;38:676-7.
7. Burgers JS, Everdingen JJE van. Evidence-based richtlijnontwikkeling in Nederland: het EBRO-platform. Ned Tijdschr Geneeskd 2004;148: 2057-9.
8. NHG en CBO. Multidisciplinaire richtlijn Maagklachten. Alphen aan den Rijn: Van Zuiden Communications; 2004.
9. Madsen LG, Bytzer P. The value of alarm features in identifying organic causes of dyspepsia. Can J Gastroenterol 2000;14:713-20.
10. Christie J, Shephard NA, Codling BW, Valori RM. Gastric cancer below the age of 55: implications for screening patients with uncomplicated dyspepsia. Gut 1997;41:513-7.
11. Canga 3rd C, Vakil N. Upper GI malignancy, uncomplicated dyspepsia, and the age threshold for early endoscopy. Am J Gastroenterol 2002;97:600-3.
12. Heikkinen M, Pikkarainen P, Takala J, Rasanen H, Julkunen R. Etiology of dyspepsia: four hundred unselected consecutive patients in general practice. Scand J Gastroenterol 1995;30:519-23.
13. Delaney BC, Innes MA, Deeks J, Wilson S, Oakes R, Moayyedi P, et al. Initial management strategies for dyspepsia [Cochrane review]. Cochrane Database Syst Rev 2000;(2):CD001961.
14. Quartero AO, Numans ME, Post MW, Melker RA de, Wit NJ de. One-year prognosis of primary care dyspepsia: predictive value of symptom pattern, Helicobacter pylori and GP management. Eur J Gastroenterol Hepatol 2002;14:55-60.
15. Lewin-van den Broek NT, Numans ME, Buskens E, Verheij TJ, Wit NJ de, Smout AJ. A randomised controlled trial of four management strategies for dyspepsia: relationships between symptom subgroups and strategy outcome. Br J Gen Pract 2001;51:619-24.
16. Delaney BC, Wilson S, Roalfe A, Roberts L, Redman V, Wearn A, et al. Randomised controlled trial of Helicobacter pylori testing and endoscopy for dyspepsia in primary care. BMJ 2001;322:898-901.
17. Vaira D, Vakil N. Blood, urine, stool, breath, money and Helicobacter pylori. Gut 2001;48:287-9.
18. Thijs JC, Zwet AA van, Thys WJ, Oei HB, Karrenbad A, Stellaard F, et al. Diagnostic tests for Helicobacter pylori: a prospective evaluation of their accuracy, without selecting a single test as the gold standard. Am J Gastroenterol 1996;191:2125-9.
19. Weijnen CF, Wit NJ de, Numans ME, Kuipers EJ, Hoes AW, Verheij TJM. Helicobacter pylori testing in the primary care setting: which diagnostic test should be used? Aliment Pharmacol Ther 2001;15: 1205-10.
20. Chiba N, Veldhuyzen van Zanten SJO, Sinclair P, Ferguson RA, Escobedo S, Grace E. Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia; the Canadian adult dyspepsia empiric treatment - Helicobacter positive (CADET-Hp) randomized controlled trial. BMJ 2002;324:1012-6.
21. Numans ME, Lau J, Wit NJ de, Bonis PA. Proefbehandeling met protonpompremmers ongeschikt als test voor gastro-oesofageale refluxziekte; een meta-analyse van de diagnostische-testeigenschappen. Ned Tijdschr Geneeskd 2004;148:1924-8.
22. Di Mario F, Battaglia G, Leandro G, Grasso G, Vianello F, Vigneri S. Short-term treatment of gastric ulcer: a meta-analytical evaluation of blind trials. Dig Dis Sci 1996;41:1108-31.
23. 2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesofagitis: a meta-analysis. Eur J Gastroenterol Hepatol 1995;7:467-75.
24. Chan FK, Leung WK. Peptic-ulcer disease. Lancet 2002;360:933-41.
25. Chiba N. Proton pump inhibitors in acute healing and maintenance of erosive or worse esophagitis: a systemic overview. Can J Gastroenterol 1997;11(Suppl B):66B-73B.
26. Bardhan KD, Muller-Lissner S, Bigard MA, Porro GB, Ponce J, Hosie J, et al. Symptomatic gastro-oesophageal disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. BMJ 1999;318:502-7.
27. Bytzer P. On-demand therapy for gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol 2001;13(Suppl 1):S19-22.
28. Kuipers EJ, Lundell L, Klinkenberg-Knol E, Havu N, Festen HPM, Liedman B, et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 1996;334:1018-22.
29. Uemura N, Okamoto S, Yamamoto S, Matsumara N, Yamaguchi M, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-8.
30. Lundell L, Mettinen P, Myrvold HE, Pedersen SA, Thor K, Andersson A, et al. Lack of effect of acid suppression therapy on gastric atrophy. Gastroenterology 1999;117:319-26.
31. Shay SS, Conwell DL, Mehindru V, Hertz B. The effect of posture on gastroesophageal reflux event frequency and composition during fasting. Am J Gastroenterol 1996;191:54-60.
32. Mullan A, Kavanagh P, O'Mahony P, Joy T, Gleeson F, Gibney MJ. Food and nutrient intakes and eating patterns in functional and organic dyspepsia. Eur J Clin Nutr 1994;48:97-105.
33. Talley NJ, Phillips SF, Bruce B, Twomey CK, Zinsmeister AR, Melton 3rd LJ. Relation among personality and symptom in nonulcer dyspepsia and the irritable bowel syndrome. Gastroenterology 1990; 99:327-33.
34. Quartero AO, Wit NJ de, Lodder AC, Numans ME, Smout AJ, Hoes AW. Disturbed solid-phase gastric emptying in functional dyspepsia: a meta-analysis. Dig Dis Sci 1998;43:2028-33.
35. Soo S, Moayyedi P, Deeks J, Delaney BC, Lewis M, Forman D. Psychological interventions for non-ulcer dyspepsia [Cochrane review], Cochrane Database Syst Rev 2001;(4):CD002301.
36. Moayyedi P, Soo S, Deeks J, Delaney BC, Harris S, Innes MA, et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia [Cochrane review]. Cochrane Database Syst Rev 2003;(1):CD002096.
37. Soo S, Moyeddi P, Deeks J, Delaney BC, Lewis M, Forman D. Psychological interventions for non-ulcer dyspepsia [Cochrane review]. Cochrane Database Syst Rev 2004;(1):CD002301.
38. Ryder SD, O'Reilly S, Miller RJ, Ross J, Jacyna MR, Levi AJ. Long term acid suppressing treatment in general practice. BMJ 1994;308: 827-30.
39. Hurenkamp GJ, Grundmeyer HG, Bindels PJ, Tytgat GN, Hulst RW van der. How do primary care physicians use long-term acid suppressant drugs? A population-based analysis of Dutch general practices. J Fam Pract 2002;51:241-5.
40. Hurenkamp GJ, Grundmeijer HG, Ende A van der, Tytgat GN, Assendelft WJ, Hulst RW van der. Arrest of chronic acid suppressant drug use after successful Helicobacter pylori eradication in patients with peptic ulcer disease: a six-month follow-up study. Aliment Pharmacol Ther 2001;15:1047-54.
41. Wit NJ de, Quartero OA, Numans ME. Helicobacter pylori treatment instead of maintenance therapy for peptic ulcer disease; the effectiveness of a case-finding strategy in general practice. Aliment Pharmacol Ther 1999;13:1317-21.
42. Numans ME, Wit NJ de, Dirven JAM, Hurenkamp GJB, Meijer QCM, Muris JWM, et al. NHG-standaard Maagklachten. Tweede herziening. Huisarts Wet 2003;46:690-700.
43. Folmer H, Wit NJ de, Festen HPM, Balen JAM van, Boer WA de, Klinkenberg-Knol EC, et al. Landelijke transmurale afspraak maagklachten. Huisarts Wet 2003;46:701-6.